Intriguingly, Zhou et al. [44] suggest that EFTUD2 may have a non-canonical role as a ubiquitin modification enzyme in the degradation of YTH domain family protein 3 (YTHDF3) in HCC, indicating the need for further investigation into its diverse functions. Here, EFTUD2 is linked to hepatocellular carcinoma.